Braskem (BAK)
(Delayed Data from NYSE)
$4.01 USD
-0.04 (-0.99%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $4.00 -0.01 (-0.25%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BAK 4.01 -0.04(-0.99%)
Will BAK be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for BAK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAK
After Plunging -18.82% in 4 Weeks, Here's Why the Trend Might Reverse for Braskem (BAK)
Wall Street Analysts Predict a 46.24% Upside in Braskem (BAK): Here's What You Should Know
BAK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Braskem (BAK) Stock?
Braskem (BAK) Is Attractively Priced Despite Fast-paced Momentum
Other News for BAK
Braskem Amends Leniency Agreement, Extends Payment Schedule
Braskem downgraded to Neutral from Outperform at Grupo Santander
Grupo Santander gets more bearish on Braskem, downgrades shares
Braskem S.A. Faces Legal Setback in Novonor Lawsuit
Braskem S.A. Files Report Highlighting Future Industry Challenges